"Dengue Vaccines: Challenge and Confrontation"
written by Guey Chuen Perng, Huan-Yao Lei, Yee-Shin Lin, Kulkanya Chokephaibulkit,
published by World Journal of Vaccines, Vol.1 No.4, 2011
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Dengue Vaccine: A Road to Dengue Prevention
2018
[2] Prevention and Control Strategies to Counter Dengue Virus Infection
Frontiers in cellular and infection microbiology, 2017
[3] Winner-take-all, take-most or pay-some? Optimal protection of innovation in a dynamic model of product development
SSRN, 2017
[4] Evaluación in vitro del efecto antiviral de compuestos derivados de plantas de la Región Caribe Colombiana sobre la infección por Virus Dengue y Virus …
2016
[5] AB Initio Structural Analysis on Envelope (E) Glycoprotein of Dengue Virus (DENV) Type 1-4
UK Journal of Pharmaceutical and Biosciences, 2016
[6] DEVELOPMENT OF DNA ELECTROCHEMICAL SENSOR BASED ON SILICON NANOWIRES/GOLD NANOPARTICLES-MODIFED ELECTRODE FOR EARLY …
2016
[7] On the optimal timing of innovation and imitation
2016
[8] When should a winner take all, or pay some? Innovation and imitation incentives in a dynamic duopoly
2016
[9] Vaccinations for travel
2015
[10] Dengue vaccines: Challenges, development, current status and prospects
Indian journal of medical microbiology, 2015
[11] Dengue risk assessment
2015
[12] On the timing of innovation and imitation
2015
[13] Anti-idiotype antibody against pre-membrane-specific antibody as an adjunct to current dengue vaccination strategy
2015
[14] Vaccine development against dengue, a viral disease of increasing significance to global public health
2014
[15] Protection against Dengue Virus Infection in Mice by Administration of Antibodies against Modified Nonstructural Protein 1
PloS one, 2014
[16] Innovation and imitation incentives in dynamic duopoly
Document de travail,Université de Lille, 2014
[17] Protection against Dengue Virus Infection in Mice by Administration of Antibodies
2014
[18] Laboratory Diagnosis of Dengue Infection: Current Techniques and Future Strategies
Open Journal of Clinical Diagnostics, 2014
[19] Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome
Journal of biomedical science, 2013
[20] Current progress in dengue vaccines
J Biomed Sci, 2013
[21] Challenges for the formulation of a universal vaccine against dengue
Experimental Biology and Medicine, 2013
[22] Anti–Dengue Virus Nonstructural Protein 1 Antibodies Cause NO-Mediated Endothelial Cell Apoptosis via Ceramide-Regulated Glycogen Synthase Kinase-3β and NF-κB Activation
The Journal of Immunology, 2013
[23] Лихорадка Денге у российских туристов, прибывших из Таиланда
2013
[24] Anti–Dengue Virus Nonstructural Protein 1 Antibodies Cause NO-Mediated Endothelial Cell Apoptosis via Ceramide-Regulated Glycogen Synthase Kinase-3β and …
2013
[25] Anti–Dengue Virus Nonstructural Protein 1 Antibodies Cause NO-Mediated Endothelial Cell Apoptosis via Ceramide-Regulated Glycogen Synthase Kinase-3β and …
2013
[26] This information is current as Activation
2013
[27] Role of microparticles in dengue virus infection and its impact on medical intervention strategies
The Yale journal of biology and medicine, 2012
[28] Evaluation of the Kinetic Change of the Immunogenicity of Dengue-2 DNA Vaccine in Mice Administered by Different Administration Routes
World Journal of Vaccines, 2012